Posted by Michael Wonder on 05 May 2021
'Intimidating' PHARMAC move may lead to child cancer drug delays
6 May 2021 - Two of New Zealand's leading cancer experts have slammed PHARMAC's proposal to take away the special exemption which gives children with cancer access to any drug they need.
Oncologists Chris Jackson and Scott McFarlane say the move is likely to mean children will face much longer waits for new paediatric oncology drugs that come on the market.
